IONIS PHARMACEUTICALS INC Income Statement
IONS / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
IONIS PHARMACEUTICALS INC reported $944M in revenue and $381M in net loss for FY2025. Revenue has grown at a 17.5% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $943.7M | $226.6M | $324.5M | $151.9M | $440.0M | $290.3M | $493.7M | $144.4M | $110.3M | $346.6M | $283.7M | $102.0M | $99.1M | $108.5M | $99.1M |
| Cost of Revenue | $15.9M | $11.2M | $9.1M | $14.1M | $4.4M | $1.8M | $0 | $0 | $0 | $0 | - | - | - | - | - |
| SG&A Expense | $393.9M | $267.5M | $232.6M | $150.3M | $286.6M | $244.6M | $108.5M | $48.6M | $108.5M | $48.6M | $37.2M | $12.5M | $12.8M | $11.7M | $12.8M |
| R&D Expense | $915.6M | $901.5M | $899.6M | - | $461.5M | $411.9M | $372.5M | $340.4M | $372.5M | $340.4M | $319.5M | $154.6M | $153.1M | $145.2M | $153.1M |
| Operating Income | -$381.7M | -$475.1M | -$353.7M | -$410.2M | $365.9M | -$61.4M | $31.0M | -$20.2M | $31.0M | -$20.2M | -$75.8M | -$68.9M | -$71.1M | -$48.4M | -$71.1M |
| Interest Expense | $17.3M | $17.0M | $12.7M | $8.1M | $12.4M | $44.8M | $44.8M | $38.8M | $44.8M | $38.8M | $36.7M | $21.2M | $16.7M | $13.2M | $16.7M |
| Income Tax | $1.8M | -$6.2M | $32.3M | $11.7M | $51.5M | -$291.1M | -$6.0M | $2.9M | -$6.0M | $2.9M | $372.0K | -$9.1M | - | - | $11.0K |
| Net Income | -$381.4M | -$453.9M | -$366.3M | -$269.7M | $278.1M | $273.7M | $346.0K | -$60.4M | $346.0K | -$60.4M | -$88.3M | -$65.5M | -$84.8M | -$61.3M | -$84.8M |
| EPS (Basic) | -$2.56 | -$1.90 | -$0.20 | -$3.18 | $2.00 | $2.09 | $0.15 | -$0.50 | -$0.74 | -$0.52 | -$0.14 | -$0.27 | - | - | $1.58 |
| EPS (Diluted) | -$2.56 | -$1.90 | -$0.20 | -$3.18 | $1.90 | $2.07 | $0.15 | -$0.50 | -$0.74 | -$0.52 | -$0.14 | -$0.27 | -$0.85 | -$0.62 | $1.58 |
| Shares Outstanding | 157.9M | 144.3M | 142.1M | 141.2M | 140.4M | 140.3M | 137.9M | 125.0M | 121.6M | 120.4M | 118.4M | 116.5M | 101.5M | 100.0M | 99.4M |
| Operating Margin | -40.5% | -209.7% | -109.0% | -270.1% | 83.2% | -21.1% | 6.3% | -14.0% | 28.1% | -5.8% | -26.7% | -67.5% | -71.8% | -44.6% | -71.8% |
| Profit Margin | -40.4% | -200.3% | -112.9% | -177.6% | 63.2% | 94.3% | 0.1% | -41.8% | 0.3% | -17.4% | -31.1% | -64.2% | -85.6% | -56.5% | -85.6% |